Metabolic dysfunction-associated steatotic liver disease fibrosis risk — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
HardGastroenterology and hepatologyMetabolic dysfunction-associated steatotic liver disease fibrosis riskRACP Adult Medicine
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Stage of liver fibrosis
In fatty liver disease, fibrosis stage is the strongest predictor of liver-related outcomes and mortality. ALT may be normal in advanced disease and does not reliably stage risk. Ultrasound steatosis, dyspepsia and triglycerides are clinically relevant but not the key prognostic determinant.
Reference: GESA fatty liver disease guidance; RACGP Red Book